NMR vs LPLA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 10, 2026

NMR

34.0
AI Score
VS
LPLA Wins

LPLA

53.4
AI Score

Investment Advisor Scores

NMR

34score
Recommendation
SELL

LPLA

53score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric NMR LPLA Winner
Revenue 10.13B 10.45B NMR
Net Income 735.66M -368.00M LPLA
Net Margin 7.3% -3.5% LPLA
ROE 12.8% -1.4% LPLA
ROA 3.7% -0.1% LPLA
Total Assets 19.79B 479.44B NMR
Cash 1.28B 7.16B NMR
Debt/Equity 1.30 4.30 LPLA
Free Cash Flow 327.14M -12.62B LPLA

Relative Price Performance (Last 90 Days)

NMR 1M: +9.6% · 3M: +25.0% LPLA 1M: -6.1% · 3M: +23.9%

Current Technical Phase

NMR

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.9% over 20 days), RSI 71

RSI (14): 71.2 · Price: $10.86

LPLA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 49.2 · Price: $353.78

Fundamentals Snapshot

Metric NMR LPLA
Market Cap
Forward P/E 14.6 11.9
Trailing P/E 12.1 28.0
Revenue (TTM)
Revenue Growth 0.3% 0.4%
Gross Margin 0.8% 0.3%
Operating Margin 0.3% 0.1%
EPS 0.87 12.40
Dividend Yield 0.03% 0.00%

Frequently Asked Questions

Based on our detailed analysis, LPLA is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.